Literature DB >> 20153914

[Contribution of in vivo confocal microscopy to diagnosis of invasive ocular surface squamous neoplasia: a case report].

R Tahiri Joutei Hassani1, E Brasnu, N Amar, L Gheck, A Labbé, M Sterkers, C Baudouin.   

Abstract

INTRODUCTION: Ocular surface squamous neoplasia (OSSN) is the most common conjunctival and limbic malignant tumor that could resemble a pterygium in the early phase of the disease. CASE REPORT: We report the case of a woman who presented with a limbic tumor of the left eye that was mistakenly diagnosed as a pterygium. An in vivo confocal microscopy examination using the HRTII Rostock Cornea Module and a surgical biopsy were performed. The in vivo confocal microscopy findings and the slit lamp examination showed characteristics that strongly supported the diagnosis of OSSN, and the histological examination of both biopsy and surgical exeresis (exenteration) confirmed the diagnosis of epidermoid carcinoma.
CONCLUSION: This case report underlines the value of in vivo confocal microscopy in the diagnosis of OSSN, particularly epidermoid carcinoma. This device could be helpful for the early differential diagnosis with pterygium.

Entities:  

Mesh:

Year:  2010        PMID: 20153914     DOI: 10.1016/j.jfo.2010.01.006

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

1.  The clinical value of in vivo confocal microscopy for diagnosis of ocular surface squamous neoplasia.

Authors:  Y Xu; Z Zhou; Y Xu; M Wang; F Liu; H Qu; J Hong
Journal:  Eye (Lond)       Date:  2012-03-09       Impact factor: 3.775

2.  Mitomycin C therapy for corneal intraepithelial neoplasia masquerading as limbal stem cell deficiency with recurrent epithelial defect.

Authors:  Nikhil S Gokhale
Journal:  Int Ophthalmol       Date:  2011-02-15       Impact factor: 2.031

3.  Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia.

Authors:  Ibrahim O Sayed-Ahmed; Sotiria Palioura; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2016-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.